Abstract
Background: Patch test (PT) is the gold standard to reveal nickel (Ni) allergy. In vitro tests are under discussion. We aimed to establish a cytokine based in vitro assay to detect Ni sensitization.Methods: From 15 patients with positive (13f, 42–78 years) and 15 with negative PT to Ni (controls, 3f, 31–82 years) within a consecutive patient series, peripheral blood mononuclear cells (PBMC) were obtained. Six‐day stimulation with three concentrations of NiSO4 was performed. Proliferative response (uptake of tritiated thymidine) and production of the cytokines IL‐1β, IL‐4, IL‐5, IL‐6, IL‐8, IL‐10, IL‐17A, TNF‐α, IFN‐γ (cytometric bead array) were assessed.Results: Twelve of fifteen Ni PT‐positive patients also had positive LTT, and all control patients were PT and LTT negative. The mean SI differed between Ni allergics and controls (P < 0.01). Upon Ni stimulation, PBMC of the allergic patients showed (i) enhanced IL‐5 response (P < 0.0001) and (ii) reduced IL‐8 production (P < 0.01). The IL‐5/IL‐8‐ratio best distinguished allergics from non‐allergics in all three Ni concentrations with a sensitivity and specificity of 93%.Conclusion: Assessment of the ratio of Ni‐induced IL‐5 and reduced IL‐8 production in vitro is a helpful tool for a better characterization of Ni‐allergic patients.

This publication has 40 references indexed in Scilit: